Wyeth Reports Earnings Results for the 2006 Third Quarter and First
PR Newswire - antidepressant globally and an important therapy in treating adult patients with major depressive disorder, generalized anxiety On October 4, Wyeth filed its dossier in Europe for PRISTIQ(TM) (desvenlafaxine succinate) to treat vasomotor symptoms
Source: sev.prnewswire.com
Click here for more information about anxiety disorder bed wetting
<< Home